Last updated: February 10, 2024
Sponsor: Nadine ATTAL
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pain (Pediatric)
Oral Facial Pain
Pain
Treatment
Sham rTMS with Hesed coil
Deep rTMS with Hesed coil
Deep active rTMS with Hesed coil
Clinical Study ID
NCT06250491
2023-A00902-43
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Chronic pain ≥ 6 months, at least 4/10 on a 0-10 NRS, present every day or nearlyevery day
- Neuropathic pain (confirmed with Douleur Neuropathique en 4 questions andinternational criteria from NeuPSIG) or fibromyalgia (revised ACR criteria)
- Stable concomitant medications for pain for at least one month
- Able to fill out questionnaires and understand and speak French
Exclusion
Exclusion Criteria:
- Contraindications to rTMS
- Prior treatment with rTMS
- Progressive severe condition (eg cancer)
- Psychosis
- Psychoactive drug abuse
Study Design
Total Participants: 100
Treatment Group(s): 3
Primary Treatment: Sham rTMS with Hesed coil
Phase:
Study Start date:
January 30, 2024
Estimated Completion Date:
April 30, 2027
Study Description
Connect with a study center
Inserm U987
Boulogne-Billancourt, 92100
FranceActive - Recruiting
Centre d'Evaluation et de Traitement de la douleur
Paris, 75014
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.